Kindle K L, Lawrence S D
Plant Science Center, Biotechnology Program, 151 Biotechnology Building, Cornell University, Ithaca, New York 14853, USA.
Plant Physiol. 1998 Mar;116(3):1179-90. doi: 10.1104/pp.116.3.1179.
We have begun to take a genetic approach to study chloroplast protein import in Chlamydomonas reinhardtii by creating deletions in the transit peptide of the gamma-subunit of chloroplast ATPase-coupling factor 1 (CF1-gamma, encoded by AtpC) and testing their effects in vivo by transforming the altered genes into an atpC mutant, and in vitro by importing mutant precursors into isolated C. reinhardtii chloroplasts. Deletions that removed 20 or 23 amino acid residues from the center of the transit peptide reduced in vitro import to an undetectable level but did not affect CF1-gamma accumulation in vivo. The CF1-gamma transit peptide does have an in vivo stroma-targeting function, since chimeric genes in which the stroma-targeting domain of the plastocyanin transit peptide was replaced by the AtpC transit peptide-coding region allowed plastocyanin to accumulate in vivo. To determine whether the transit peptide deletions were impaired in in vivo stroma targeting, mutant and wild-type AtpC transit peptide-coding regions were fused to the bacterial ble gene, which confers bleomycin resistance. Although 25% of the wild-type fusion protein was associated with chloroplasts, proteins with transit peptide deletions remained almost entirely cytosolic. These results suggest that even severely impaired in vivo chloroplast protein import probably does not limit the accumulation of CF1-gamma.
我们已经开始采用遗传学方法来研究莱茵衣藻中叶绿体蛋白的导入,具体做法是对叶绿体ATP酶偶联因子1(CF1-γ,由AtpC编码)的γ亚基的转运肽进行缺失突变,并通过将改变后的基因转化到atpC突变体中在体内进行测试,以及通过将突变前体导入分离的莱茵衣藻叶绿体中在体外进行测试。从转运肽中心去除20或23个氨基酸残基的缺失突变使体外导入降低到无法检测的水平,但不影响CF1-γ在体内的积累。CF1-γ转运肽确实具有体内基质靶向功能,因为嵌合基因中质体蓝素转运肽的基质靶向结构域被AtpC转运肽编码区取代后,质体蓝素能够在体内积累。为了确定转运肽缺失突变在体内基质靶向中是否受损,将突变型和野生型AtpC转运肽编码区与赋予博来霉素抗性的细菌ble基因融合。虽然25%的野生型融合蛋白与叶绿体相关,但具有转运肽缺失的蛋白几乎完全保留在细胞质中。这些结果表明,即使体内叶绿体蛋白导入严重受损,可能也不会限制CF1-γ的积累。